Status:
COMPLETED
Electronic Monitoring and Improvement of Adherence to DOACs in Polymedicated Stroke Patients
Lead Sponsor:
University Hospital, Basel, Switzerland
Collaborating Sponsors:
University of Basel
Clinical Trial Unit, University Hospital Basel, Switzerland
Conditions:
Adherence, Patient
Stroke, Ischemic
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Primary objective of the MAAESTRO trial is to evaluate the impact of an educational and reminder-based intervention on the adherence of stroke patients to DOACs. Secondary objectives are to evaluate t...
Eligibility Criteria
Inclusion
- Signed informed consent form (ICF)
- Adult patients (≥ 18 years)
- Hospitalization for acute ischaemic stroke (including TIA with positive neuroimaging)
- DOAC treatment for atrial fibrillation or embolic stroke of undetermined source
- Patients receiving polypharmacy, defined as at least 3 drugs (including DOAC treatment)
- Patients self-administering their medication
- Patients already using a pillbox or willing to use one
Exclusion
- Patients not able or unwilling to sign ICF
- Medication administration by caregiver - Filling of the pillbox by a pharmacy, relatives or other caregivers does not exclude the patients, provided that they self-administer their medication
- Patients who are, in the opinion of the investigator, unlikely to adhere to the study schedule or are unsuitable for any other reason
Key Trial Info
Start Date :
December 1 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 14 2022
Estimated Enrollment :
130 Patients enrolled
Trial Details
Trial ID
NCT03344146
Start Date
December 1 2017
End Date
March 14 2022
Last Update
December 21 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital Basel
Basel, Switzerland, 4031